Saturday, September 14, 2013

Pharmalgin

Pharmalgin
For The Medical Profeasion Only Oblong Pharmalgin Tablets Analgesic, antipyretic, Spasmolytic antiph logistic.
Composition
Each 
tablet contains: Analgin 500mg
Properties: Pharmalgin has analgesic, antipyretic, spasmolytic and
antiphloistic effects. 
Indications: Used when have advantage on other analgesics. pain in rheumatic disorders, headache and toothache. Pain after injuries and operations. Spasmodic pain in the gastrointestinal tract, the biliary tract, kidneys and lower urinary tract for lowering high temperature in febrile diseases. Contraindications: Pharmalgin must not be used in patients with pyrazolone allergy, hepatic porphyria or congenital glucose phosphate dehydrogenase deficiency, lactation.
Interactions:
The patient must be warned against the simultaneous consumption of alcohol because pharmalgin may increase the alcohol effect.
Side 
Effects: Acute renal insufficiency or nephropathy, hypersensitivity & disturbance of white blood cell count rarely occur during treatment with this preparation as well as with other pyrazolone derivatives, If during prolonged treatment the well being of the patient is impaired, the leucocytic count should be checked and in case of granulocytopenia the drug must be discontinued. Anaemia, thrombocytopenia, agranulocytoses, shock, urticaria, stevens Johnson syndrome, asthmatic attack occur due to hypersensitivity, appearance of red colour in urine of acidic PH may occur.
Precautions:
Analgesics in general should not be given to infants less than 4 months age, during pregnancy, particularly the first 3 months & the last 6 weeks & in patients with haematopoietic disorders. 
Warning: Do not exceed the prescribed dose to avoid convulsions. Dosage & administration: Unless otherwise prescribed by the physician, the following dosage are recommended.
Adults: 2 tablets 1-3 times per day.
Smallest single dose: one tablet.
Maximum daily dose: 2 tablets four times daily.
Package:lO oblong tablets.
Manufactured by The Arab Drug Company
Cairo 
A.R.E. ADCO

No comments:

Post a Comment